New hope for early pancreatic cancer intervention via AI-bas

PRISM, developed by MIT CSAIL, is a pancreatic cancer risk prediction model using a vast, federated network of electronic health records from numerous U.S. healthcare organizations.

Related Keywords

United States , David Avigan , Martin Rinard , Limor Appelbaum , Kai Jia , Artificial Intelligence Laboratory , Defense Advanced Research Projects Agency , Cancer Foundation , Boeing , Harvard Medical School , National Science Foundation , Radiation Oncology , Beth Israel Deaconess Medical Center , Investigator Martin Rinard , Prevent Cancer Foundation , Mit Csail , Ancreatic Duct Adenocarcinoma Pdac , Dac Risk Model Prism , Prismnn , Rismlr , Pancreatic Cancer Research , Electronic Health Records , Risk Prediction , Federated Data , Eth Israel Deaconess Medical Center Bidmc , Mai Jia , Rtificial Neural Networks , Logistic Regression ,